Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
blood plasma (2 trials)
cryoprecipitate (1 trial)
ringer's lactate (1 trial)
red blood cells (3 trials)
s303 red blood cells (3 trials)
autologous platelets (1 trial)
intercept platelets (1 trial)
Anemia (Phase 3)
beta-Thalassemia (Phase 3)
Hemorrhagic Fever, Ebola (Phase 1)
Lung Injury (Phase 4)
Thalassemia (Phase 3)
Virus Diseases (Phase 1)
Trials (8 total)
Trial APIs (7 total)